MYBPC2 and skeletal muscle disorder: Studies have shown that lack of Mybpc2 expression can lead to severe skeletal myopathy, increased apoptosis, up-regulated expression of factors related to muscle protein degradation, accompanied by structural changes and muscle weakness (Li et al., 2016).